Studies on disease-modifying antirheumatic drugs: Synthesis of novel quinoline and quinazoline derivatives and their anti-inflammatory effect

Journal of Medicinal Chemistry

Volumn 39, Issue 26, 1996, Pages 5176-5182

  Baba, Atsuo ^a   Kawamura, Noriaki ^a   Makino, Haruhiko ^a   Ohta, Yoshikazu ^a   Taketomi, Shigehisa ^a   Sohda, Takashi ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; CYTOKINE; GAMMA INTERFERON; IMIDAZOLE; INTERLEUKIN 4; MITOGENIC AGENT; PROSTAGLANDIN E2; QUINAZOLINE DERIVATIVE; QUINOLINE DERIVATIVE; TRIAZOLE;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENCY; DRUG SYNTHESIS; IMMUNOMODULATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; OSTEOLYSIS; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; BONE RESORPTION; DINOPROSTONE; DISEASE MODELS, ANIMAL; FEMALE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PREGNANCY; QUINAZOLINES; QUINOLINES; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030450411     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9509408     Document Type: Article

References (24)

1. Sokoloff, L.; Hough, A. J., Jr. Pathology of Rheumatoid Arthritis and Allied Disorders. In Arthritis and Allied Conditions. A Textbook of Rheumatology, 10th ed.; McCarty, D. J., Ed.; Lea & Febiger: Philadelphia, PA, 1985; pp 571-592.
2. Stecher, V. J.; Carlson, J. A.; Connolly, K. M.; Bailey, D. M. Disease-Modifying Antirheumatic Drugs. Med. Res. Rev. 1985, 5, 371-390.
3. (a) McClloch, J.; Lydyard, P. M.; Rook, G. A. W. Rheumatoid Arthritis: How Well Do the Theories Fit the Evidence? Clin. Exp. Immunol. 1993, 92, 1-6.
4. (b) Panayi, G. S.; Lanchbury, J. S.; Kingsley, G. H. The Importance of the T Cell in Initiating and Maintaining the Chronic Synovitis of Rheumatoid Arthritis. Arthritis Rheum. 1992, 35, 729-733.
5. (c) Wick, I.; McColl, G.; Harrison, L. New Perspectives on Rheumatoid Arthritis. Immunol. Today 1994, 75, 553-556.
6. (a) Hori, N.; Tsukamoto, G.; Imamura, A.; Ohashi, M.; Saito, T.; Yoshino, K. Novel Disease-Modifying Antirheumatic Drugs. I. Synthesis and Antiarthritic Activity of 2-(4-Methylphenyl)-benzothiazoles. Chem. Pharm. Bull. 1992, 40, 2387-2390.
7. (b) Fujisawa, H.; Nishimura, T.; Inoue, Y.; Ogaya, S.; Shibata, Y.; Nakagawa, Y.; Sato, S.; Kimura, K. Antiinflammatory Properties of the New Antirheumatic Agent 4-Acetylaminophenylacetic Acid. Arzneim.-Forsch./Drug Res. 1990, 40, 693-697.
8. (c) Nakamura, K.; Tsuji, K.; Konishi, N.; Okumura, H.; Matsuo, M. Studies on Antiinflammatory Agents. II. Synthesis and Pharmacological Properties of 2́-(Phenylthio)methanesulfonanilides and Related Derivatives. Chem. Pharm. Bull. 1993, 41, 894-906.
9. (d) Mizukoshi, S.; Tsukamoto, M.; Tanaka, H.; Nakamura, K.; Kato, F. Anti-inflammatory and Immunosuppressive Effects of 1,6-Anhydro-3,4-dideoxy-2-furfuryl-β-D-threo-3-enopyranose (MT2221), a Novel Anhydro-enopyranose Derivatives, on Experimental Animal Models. Biol. Pharm. Bull. 1994, 17, 1070-1074.
10. (a) Lipsky, P. E.; Davis, L. S.; Cush, D. J.; Oppenheimer-Marks, N. The Role of Cytokines in the Pathogenesis of Rheumatoid Arthritis. Springer Semin. Immunopathol. 1989, 11, 123-162.
11. (b) Gowen, M.; Mundy, G. R. Actions of Recombinant Interleukin 1, Interleukin 2, and Interferon-γ on Bone Resorption in vitro. J. Immunol. 1986, 136, 2478-2482.
12. (a) Sohda, T.; Tsuda, M.; Naruse, Y.; Taketomi, S. Naphthofuranones for treatment of osteoporosis. Chem. Abstr. 1993, 118, 175771J.
13. (b) Sohda, T.; Tsuda, M.; Naruse, Y.; Taketomi, S. Jpn. Kokai Tokkyo Koho JP 04,211,609, 1992.
14. Cheng, C.-C.; Yan, S.-J. The Friedländer Synthesis of Quinolines. Org. React. 1982, 28, 37-201.
15. Sternbach, L. H.; Fryer, R. I.; Metlesics, W.; Sach, G.; Stempel, A. Quinazolines and 1,4-Benzodiazepines. V. o-Aminobenzophenones. J. Org. Chem. 1962, 27, 3781-3788.
16. Preparation of the requisite (3-halopropyl)- or (4-halobutyl)-quinolines was undertaken, but favorable results were not obtained.
17. Brooks, D. W.; Lu, L. D.-L.; Masamune, S. C-Acylation under Virtually Neutral Conditions. Angew. Chem., Int. Ed. Engl. 1979, 18, 72-73.
18. (a) Ohta, Y.; Makino, H.; Fukuda, S.; Baba, A.; Nagai, H.; Tsukuda, R.; Sohda, T.; Shimamoto, N. TAK-603, A New Anti-Rheumatic Drug, Suppresses Autoimmune Reactions and Prevents Articular Destruction. Arthritis Rheum. 1995, 35 (Suppl. 9), S373.
19. (b) Ohta, Y.; Fukuda, S.; Baba, A.; Nagai, H.; Tsukuda, R.; Sohda, T.; Makino, H. Immunomodulating and Articular Protecting Activities of a New Anti-rheumatic Drug, TAK-603. Immunopharmacology 1996, 34, 17-26.
20. In Raisz's assay, we also examined the effect of 12d on LDH release, as an index of cellular toxicity. No increase in LDH release was observed after incubation with 12d for 2 days. So, bone resorption inhibitory effects of 12d are not due to cellular toxicity.
21. The SAR with regard to bone resorption inhibitory effects of these novel quinoline and quinazoline derivatives was presented at AFMC International Medicinal Chemistry Symposium 95 (AIMECS 95), The Pharmaceutical Society of Japan, Tokyo, Japan, Sept. 3-8, 1995; Abstract pp 108.
22. Pearson, C. M. Development of Arthritis, Periarthritis and Periostitis in Rats Given Adjuvants. Proc. Soc. Exp. Biol. Med. 1956, 91, 95-101.
23. (a) Raisz, L. G. Bone Resorption in Tissue Culture. Factors Influencing the Response to Parathyroid Hormone. J. Clin. Invest. 1965, 44, 103-116.
24. (b) Tsuda, M.; Kitazaki, T.; Ito, T.; Fujita, T. The Effect of Ipriflavone (TC-80) on Bone Resorption in Tissue Culture. J. Bone Mineral Res. 1986, 1, 207-211.